COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?
Saved in:
Main Authors: | Pugazhenthan Thangaraju (Author), Meenalotchini Prakash gurunthalingam (Author), Sajitha venkatesan (Author), Eswaran Thangaraju (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Final leprosy push: Out of society
by: Pugazhenthan Thangaraju, et al.
Published: (2018) -
Mycobacterium leprae or Tuberculosis: A diagnostic dilemma
by: Pugazhenthan Thangaraju, et al.
Published: (2017) -
Drug flibanserin-in hypoactive sexual desire disorder
by: Pugazhenthan Thangaraju, et al.
Published: (2022) -
Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
by: Pugazhenthan Thangaraju, MD, et al.
Published: (2022) -
Retrospective analysis of drug prescription statistics in a tertiary care center in India: Recommendations for promoting prudent utilization of drugs
by: Ajaya Kumar Sahoo, et al.
Published: (2020)